Antimicrobial materials developer AgION, which raised a $3M Series D from two strategic investors
back in September, announced that
they have added $5M to the round.
The new capital came in from new and existing investors including SAM Private Equity, Prescher Capital, Paladin Capital Group, BASF Venture Capital, and Motorola Ventures. AgION has now raised a total of $45.7M. SAM Private Equity appears to have played a lead role in bringing in the new funding.